Supramolecular Aggregate as a High-Efficiency Gene Carrier Mediated with Optimized Assembly Structure
Authors:
- 21 October 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 8 (43) , 29343-29355
Abstract
For cancer gene therapy, a safe and high-efficient gene carrier is a must. To resolve the contradiction between gene transfection efficiency and cytotoxicity, many polymers with complex topological structures have been synthesized, although their synthesis processes and structure control are difficult as well as the high molecular weight also bring high cytotoxicity. We proposed an alternative strategy that uses supramolecular inclusion to construct the aggregate from the small molecules for gene delivery, and to further explore the relationship between the topological assembly structure and their ability to deliver gene. Herein, PEI-1.8k-conjugating β-CD through 6-hydroxyl (PEI-6-CD) and 2-hydroxyl (PEI-2-CD) have been synthesized respectively and then assembled with diferrocene (Fc)-ended polyethylene glycol (PEG-Fc). The obtained aggregates were then used to deliver MMP-9 shRNA plasmid for MCF-7 cancer therapy. It was found that the higher gene transfection efficiency can be obtained by selecting PEI-2-CD as the host and tuning the host/guest molar ratios. With the rational modulation of supramolecular architectures, the aggregate played the functions similar to macromolecules which exhibit higher transfection efficiency than PEI-25k, but show much lower cytotoxicity because of the nature of small/low molecules. In vitro and in vivo assays confirmed that the aggregate could deliver MMP-9 shRNA plasmid effectively into MCF-7 cells and then downregulate MMP-9 expression, which induced the significant MCF-7 cell apoptosis, as well inhibit MCF-7 tumor growth with low toxicity. The supramolecular aggregates maybe become a promising carrier for cancer gene therapy and also provided an alternative strategy for designing new gene carriers.Keywords
Funding Information
- National Natural Science Foundation of China (31271019, 51573071)
- Guangzhou Science, Technology and Innovation Commission (201506010069)
- Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, Southern Medical University
- Natural Science Foundation of Guangdong Province (2014A030313361)
This publication has 43 references indexed in Scilit:
- Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cellsCancer Gene Therapy, 2010
- Melittin Suppresses PMA-Induced Tumor Cell Invasion by Inhibiting NF-κB and AP-1-Dependent MMP-9 ExpressionMolecules and Cells, 2010
- Aqueous Solubilization of Fullerenes Using Poly(amidoamine) Dendrimers Bearing Cyclodextrin and Poly(ethylene Glycol)Bioconjugate Chemistry, 2008
- Progress in developing cationic vectors for non-viral systemic gene therapy against cancerBiomaterials, 2008
- Breaking up the correlation between efficacy and toxicity for nonviral gene deliveryProceedings of the National Academy of Sciences, 2007
- UV–vis and FTIR–ATR spectroscopic techniques to study the inclusion complexes of genistein with β-cyclodextrinsJournal of Pharmaceutical and Biomedical Analysis, 2007
- Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapyJournal of Controlled Release, 2007
- Polymers for gene delivery across length scalesNature Materials, 2006
- Gene Therapy Progress and Prospects: Nonviral vectorsGene Therapy, 2002
- Selective Functionalization and Flexible Coupling of Cyclodextrins at the Secondary Hydroxyl FaceThe Journal of Organic Chemistry, 1995